epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove gemcitabine
    generic
  • remove Lotrimin AF Cream
    clotrimazole topical
  • remove Onglyza
    saxagliptin
  • remove Temodar
    temozolomide
  • remove Trijardy XR
    empagliflozin/ linagliptin/ metformin
  • remove Vonjo
    pacritinib
  • remove Zelsuvmi
    berdazimer topical

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Avoid/Use Alternative
Smiley face Smiley face Onglyza (saxagliptin) + Trijardy XR (empagliflozin/ linagliptin/ metformin)

Avoid/Use Alternative

saxagliptin + linagliptin

avoid combo: combo may incr. risk of hypoglycemia, cardiotoxicity, other adverse effects (additive effects, duplicate therapy)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information